Areeg Mohammad Medhat Dabbish

Mrs. Areeg Mohammad Medhat Dabbish

The American University in Cairo
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ADAreeg Mohammad Medhat Dabbish
Areeg Mohammad Medhat Dabbish
HAHana Abdelzaher
Hana Abdelzaher
MAMoustafa Abohawya
Moustafa Abohawya
SSSamir Shamma
Samir Shamma
YMYosra H. Mahmoud
Yosra H. Mahmoud
AAAnwar Abdelnaser
Anwar Abdelnaser
Early detection of hepatocellular carcinoma (HCC) will reduce morbidity and mortality rates of this widely spread disease. Dysregulation in microRNA (miRNA) expression is associated with HCC progression. The objective is to identify a panel of differentially expressed miRNAs (DE-miRNAs) to enhance HCC early prediction in hepatitis C virus (HCV) infected patients. Candidate miRNAs were selected using a bioinformatic analysis of microarray and RNA-sequencing datasets, resulting in nine DE-miRNAs (miR-142, miR-150, miR-183, miR-199a, miR-215, miR-217, miR-224, miR-424, and miR-3607). Their expressions were validated in the serum of 44 healthy individuals, 62 non-cirrhotic HCV patients, 67 cirrhotic-HCV, and 72 HCV-associated-HCC patients using real-time PCR (qPCR). There was a significant increase in serum concentrations of the nine-candidate miRNAs in HCC and HCV patients relative to healthy individuals. MiR-424, miR-199a, miR-142, and miR-224 expressions were significantly altered in HCC compared to non-cirrhotic patients. A panel of five miRNAs improved sensitivity and specificity of HCC detection to 100% and 95.12% relative to healthy controls. Distinguishing HCC from HCV-treated patients was achieved by 70.8% sensitivity and 61.9% specificity using the combined panel, compared to alpha-fetoprotein (51.4% sensitivity and 60.67% specificity). These preliminary data show that the novel miRNAs panel (miR-150, miR-199a, miR-224, miR-424, and miR-3607) could serve as a potential non-invasive biomarker for HCC early prediction in chronic HCV patients. Further prospective studies on a larger cohort of patients should be conducted to assess the potential prognostic ability of the miRNAs panel.

9 January 2025 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
NYNouran Yonis
Nouran Yonis
AMAhmed Mousa
Ahmed Mousa
MYMohamed H. Yousef
Mohamed H. Yousef
AGAhmed M. Ghouneimy
Ahmed M. Ghouneimy
ADAreeg Mohammad Medhat Dabbish
Areeg Mohammad Medhat Dabbish
AAAnwar Abdelnaser
Anwar Abdelnaser